ATCT-01PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG).
| Image |  |
|---|---|
| Description | scientific article published on 9 November 2015 |
| Author/s |
author: Woody Massey Annick Desjardins Katherine B Peters Eric Lipp Mary Lou Affronti Henry Seth Friedman James H. Herndon Dina Randazzo |
| Publication date | November 9, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |